Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria

Tekijä Hamaoka, T, Costelloe, C M, Madewell, J E, Liu, P, Hortobagyi, G N, Ueno, N T
Julkaistu 2010

Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer

Tekijä Hamaoka, T, Costelloe, C M, Madewell, J E, Liu, P, Berry, D A, Islam, R, Theriault, R L, Hortobagyi, G N, Ueno, N T
Julkaistu 2010

Osseous Pseudoprogression in Vertebral Bodies Treated with Stereotactic Radiosurgery: A Secondary Analysis of Prospective Phase I/II Clinical Trials

Tekijä Amini, B., Beaman, C.B., Madewell, J.E., Allen, P.K., Rhines, L.D., Tatsui, C.E., Tannir, N.M., Li, J., Brown, P.D., Ghia, A.J.
Julkaisussa AJNR Am J Neuroradiol (2016)

Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard

Tekijä Livingston, J. A., Bugano, D., Barbo, A., Lin, H., Madewell, J. E., Wang, W. L., Lazar, A. J., Tseng, W. W., Roland, C. L., Feig, B. W., Pollock, R., Conley, A. P., Benjamin, R. S., Patel, S., Somaiah, N.
Julkaisussa Sci Rep (2017)

Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI

Tekijä Guo, J, Glass, J O, McCarville, M B, Shulkin, B L, Daryani, V M, Stewart, C F, Wu, J, Mao, S, Dwek, J R, Fayad, L M, Madewell, J E, Navid, F, Daw, N C, Reddick, W E
Julkaisussa Br J Cancer (2015)